Avadel Pharmaceuticals earnings were -$48.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest AVDL earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$5.0M, up 92.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AVDL reported annual earnings of -$48.8M, with -69.5% growth. The next AVDL earnings date is May 6, 2025.
Avadel Pharmaceuticals Earnings Reports & History FAQ
What were Avadel Pharmaceuticals's earnings last quarter?
Avadel Pharmaceuticals (NASDAQ: AVDL) reported Q4 2024 earnings per share (EPS) of -$0.05, up 82.76% year over year. Total AVDL earnings for the quarter were -$5.04 million. In the same quarter last year, Avadel Pharmaceuticals's earnings per share (EPS) was -$0.29.
The next AVDL earnings call is Invalid Date. Add AVDL to your watchlist to be reminded of Avadel Pharmaceuticals's next earnings date.
What was AVDL's earnings growth in the past year?
As of Avadel Pharmaceuticals's earnings date in Q1 2025, Avadel Pharmaceuticals's earnings has grown year over year. AVDL earnings in the past year totalled -$48.83 million.
Is Avadel Pharmaceuticals profitable or losing money?
As of the last Avadel Pharmaceuticals earnings report, Avadel Pharmaceuticals is currently losing money. Avadel Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$48.83 million, a 69.53% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.